Matches in Nanopublications for { ?s ?p "[NRG3 was expressed in 42% of breast cancers studied/was preferentially expressed in breast tumors co-expressing EGFR/HER4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP109811.RAfzd02JHyuAHEyBtd_sbeQ8fRaR-mVvZMeYvMh7cWrQY130_assertion description "[NRG3 was expressed in 42% of breast cancers studied/was preferentially expressed in breast tumors co-expressing EGFR/HER4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109811.RAfzd02JHyuAHEyBtd_sbeQ8fRaR-mVvZMeYvMh7cWrQY130_provenance.
- NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_assertion description "[NRG3 was expressed in 42% of breast cancers studied/was preferentially expressed in breast tumors co-expressing EGFR/HER4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_provenance.
- assertion description "[NRG3 was expressed in 42% of breast cancers studied/was preferentially expressed in breast tumors co-expressing EGFR/HER4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_assertion description "[NRG3 was expressed in 42% of breast cancers studied/was preferentially expressed in breast tumors co-expressing EGFR/HER4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173024.RAoqf0PGESDBryYEqf6WAvWoaQM4001XYfxbmg7_gUXiA130_provenance.
- NP176418.RAiZ-F1gHyhbo2v80ixuusQC60y7alxhBOupyKJA3Ox70130_assertion description "[NRG3 was expressed in 42% of breast cancers studied/was preferentially expressed in breast tumors co-expressing EGFR/HER4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP176418.RAiZ-F1gHyhbo2v80ixuusQC60y7alxhBOupyKJA3Ox70130_provenance.
- NP230623.RAFf3lbKMjptW8DAGTMX7sl6rqTQd7RgURfwhRZ89Ws6o130_assertion description "[NRG3 was expressed in 42% of breast cancers studied/was preferentially expressed in breast tumors co-expressing EGFR/HER4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230623.RAFf3lbKMjptW8DAGTMX7sl6rqTQd7RgURfwhRZ89Ws6o130_provenance.